Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Dec 27;36(2):278–297. doi: 10.1007/s12325-018-0859-x

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 4 — Forest plot of the mean differences (and 95% confidence intervals) between patients treated with the olmesartan 40 mg plus amlodipine 10 mg (OLM/AML, n = 221) and the perindopril 8 mg plus amlodipine 10 mg (PER/AML, n = 221) combination in the absolute change from baseline to the final examination in systolic blood pressure (SBP) and diastolic blood pressure (DBP). p values represent the superiority comparison between the two treatment groups.

Reprinted by permission from Springer Nature Customer Service Centre GmbH: Springer, Advances in Therapy, (The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension, Luis Ruilope; Angie Schaefer, 2013